title: [Chlamydia pneumoniae and Mycoplasma pneumoniae pneumonia in children].
abstract: Chlamydia pneumoniae and Mycoplasma pneumoniae are frequently involved in lower respiratory tract infections in children. Their responsibility must be evoked whenever an antibiotic treatment has been prescribed for a suspected bacterial origin, without clinical improvement (persistent fever particularly) after 48 hours. This must lead to the prescription of a macrolide.
authors.affiliation: Service des explorations fonctionnelles respiratoires, hôpital Saint-Vincent-de-Paul, Paris, France.
authors.forename: J L
authors.initials: JL
authors.lastname: Iniguez
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002690:Chlamydia Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D016993:Chlamydophila pneumoniae; D005602:France / Q000453:epidemiology; D006801:Humans; D009177:Mycoplasma pneumoniae; D018410:Pneumonia, Bacterial / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D011019:Pneumonia, Mycoplasma / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology
chemical_list: D000900:Anti-Bacterial Agents